Latest Headlines

  1. Arterys’ Oncology Imaging Suite With Deep Learning Cleared By FDA

    Arterys Inc., the leader in intelligent, cloud-based medical imaging software solutions, recently announced its fifth 510(k) clearance from the U.S. Food and Drug Administration (FDA).

  2. BD Announces Q1 2018 Results; Updates 2018 Fiscal 2018 Guidance To Include Bard

    BD (Becton, Dickinson and Company), a leading global medical technology company, recently reported quarterly revenues of $3.080 billion for the first fiscal quarter ended December 31, 2017.

  3. Worrell Announces U.S. Expansion With Denver’s Catalyst HTI

    Global healthcare design, strategy and innovation firm, Worrell, Inc. announced it will join Kaiser Permanente, Medical Group Management Association, Delta Dental, Prime Health, University of Colorado, AngelMD and dozens of health tech startups in Catalyst HTI, a new Denver health-care innovation hub opening June of this year. Catalyst HTI is the first facility of its kind in the United States, designed to bring together stakeholders from across the healthcare market to foster collaboration and accelerate innovation.

  4. Embrace Becomes First FDA-Cleared Seizure-Monitoring Smart Watch

    Empatica Inc has received clearance from the FDA for Embrace, its award-winning smart watch. Embrace uses AI (advanced machine learning) to monitor for the most dangerous kinds of seizures, known as "grand mal" or "generalized tonic-clonic" seizures, and send an alert to summon caregivers' help.

  5. Researchers Create Fiber Optic Sensors That Dissolve In The Body

    For the first time, researchers have fabricated sensing elements known as fiber Bragg gratings inside optical fibers designed to dissolve completely inside the body.


  6. Varian Acquires Mobius Medical Systems

    Varian  recently announced it has acquired privately-held Mobius Medical Systems®, a leader in radiation oncology Quality Assurance (QA) software.

  7. Outsourced Pharma Announces Philadelphia Agenda

    Outsourced Pharma announces its Philadelphia agenda. Fundamentals for Outsourcing Drug Development and Manufacturing is scheduled for July 18 and 19, 2018 in Philadelphia.

  8. Phillips-Medisize Presents Innovative Packaging Concepts And Connected Drug Delivery Devices During Pharmapack Paris

    Phillips-Medisize, a Molex company will showcase its continuum of contract services including device strategy, product development and manufacture across pharmaceutical primary packaging and specialty drug delivery devices, dosing & dispensing systems, inhalators, spray applicators, as well as wearable drug delivery devices designed to improve patient engagement and drive better outcomes.

  9. Greenlight Guru Revenue Rockets In Q4, Plans Hiring Spree In Q1
  10. NUS Researchers Develop Wireless Light Switch For Targeted Cancer Therapy

    A team of scientists from the National University of Singapore (NUS) has developed a way to wirelessly deliver light into deep regions of the body to activate light-sensitive drugs for photodynamic therapy (PDT).